OSR HEALTH, INC. Financing Cash Flow
OSR HEALTH, INC. (OSRH) reported Financing Cash Flow of $3.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- OSR HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.47M, a 177.40% increase year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $942.10K, a 530.67% increase year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.21M, a 898.89% increase year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.12M, a 1117.78% increase year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2025 was $8.37M, a 606.57% increase from fiscal 2024.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2024 was $1.18M, a 96.57% decline from fiscal 2023.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2023 was $34.54M, a 27759.15% increase from fiscal 2022.
- OSR HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2022 was $123.98K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.42M 10-Q · filed 2026-08-14 | $6.63M derived: sum of 3 quarters · filed 2026-08-14 | $10.74M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $942.10K 10-Q · filed 2026-05-13 | $4.15M derived: sum of 2 quarters · filed 2026-05-13 | $8.27M derived: sum of 3 quarters · filed 2026-05-13 | $9.16M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.33M derived: sum of 2 quarters · filed 2026-03-31 | $8.22M derived: sum of 3 quarters · filed 2026-08-14 | $8.37M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $4.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.01M derived: sum of 2 quarters · filed 2026-08-14 | $5.16M 10-Q · filed 2025-11-12 | $5.48M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $891.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.04M 10-Q · filed 2026-08-14 | $1.36M derived: sum of 3 quarters · filed 2026-08-14 | $1.70M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $149.38K 10-Q · filed 2026-05-13 | $149.38K 10-Q · filed 2025-05-20 | $470.90K derived: sum of 2 quarters · filed 2026-05-13 | $808.87K derived: sum of 3 quarters · filed 2026-05-13 | $1.07M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $321.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $659.49K derived: sum of 2 quarters · filed 2026-03-31 | $917.75K derived: sum of 3 quarters · filed 2026-03-31 | $1.18M 10-K · filed 2026-03-31 | -$33.67M 10-K · filed 2025-04-22 | |||
| 2024-09-30 | $337.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $596.24K derived: sum of 2 quarters · filed 2025-11-12 | $862.82K 10-Q · filed 2025-11-12 | -$15.25M 10-Q · filed 2024-11-14 | -$35.28M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $258.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $524.85K 10-Q · filed 2025-08-14 | -$15.52M 10-Q · filed 2024-08-19 | -$35.62M derived: sum of 3 quarters · filed 2025-08-14 | -$35.42M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $266.58K 10-Q · filed 2025-05-20 | $150.00K 10-Q · filed 2024-05-15 | -$35.87M derived: sum of 2 quarters · filed 2025-05-20 | -$35.67M derived: sum of 3 quarters · filed 2025-05-20 | -$35.67M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | -$36.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-22 | -$35.94M derived: sum of 2 quarters · filed 2025-04-22 | -$35.94M derived: sum of 3 quarters · filed 2025-04-22 | $34.54M 10-K · filed 2025-04-22 | ||||
| 2023-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $200.00K derived: sum of 2 quarters · filed 2024-11-14 | $70.68M 10-Q · filed 2024-11-14 | $70.74M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $70.48M 10-Q · filed 2024-08-19 | $70.54M derived: sum of 3 quarters · filed 2024-08-19 | $70.53M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $70.48M 10-Q · filed 2024-05-15 | $70.54M derived: sum of 2 quarters · filed 2024-05-15 | $70.53M derived: sum of 3 quarters · filed 2024-05-15 | $70.59M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $56.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $47.49K derived: sum of 2 quarters · filed 2024-04-17 | $112.22K derived: sum of 3 quarters · filed 2024-04-17 | $123.98K 10-K · filed 2024-04-17 | ||||
| 2022-09-30 | -$9.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $55.60K derived: sum of 2 quarters · filed 2023-11-07 | $67.36K 10-Q · filed 2023-11-07 | |||||
| 2022-06-30 | $64.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $76.49K 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $11.76K 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | -$57.44K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |